A recent prospective cohort and Mendelian randomization analysis concluded that CRP was a potential biomarker to assess overall cancer risks as well as 12 site-specific cancers, while there was no association for genetically predicted CRP and cancer risks [776]. This evidence concerns the gene CRP and cancer.